Cargando…

Negative feedback regulation within NO/cGMP pathway attenuates vasodilatory response in renovascular hypertension

Detalles Bibliográficos
Autores principales:	Mergia, Evanthia, Stegbauer, Johannes, Friedrich, Sebastian, Quack, Ivo, Rump, Lars Christian, Koesling, Doris
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2009
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3313361/ http://dx.doi.org/10.1186/1471-2210-9-S1-P48

Ejemplares similares

Phosphodiesterase 5 Attenuates the Vasodilatory Response in Renovascular Hypertension
por: Stegbauer, Johannes, et al.
Publicado: (2013)

PDE2, a component of the NO/cGMP signalling in the hippocampus
por: Schönle, Isabel, et al.
Publicado: (2011)

Role of Phosphodiesterase 5 and Cyclic GMP in Hypertension
por: Mergia, Evanthia, et al.
Publicado: (2016)

Direct activation of PDE5 by cGMP: long-term effects within NO/cGMP signaling
por: Mullershausen, Florian, et al.
Publicado: (2003)

cGMP Imaging in Brain Slices Reveals Brain Region-Specific Activity of NO-Sensitive Guanylyl Cyclases (NO-GCs) and NO-GC Stimulators
por: Peters, Stefanie, et al.
Publicado: (2018)

It takes two to tango: cardiac fibroblast-derived NO-induced cGMP enters cardiac myocytes and increases cAMP by inhibiting PDE3
por: Menges, Lukas, et al.
Publicado: (2023)

NO-dependent cGMP signalling in neurons and astrocytes
por: Giesen, Jan, et al.
Publicado: (2015)

cGMP signals in smooth muscle cells and cardiac myocytes
por: Krawutschke, Christian, et al.
Publicado: (2011)

Nitric oxide dependent signaling via cyclic GMP in dendritic cells regulates migration and T-cell polarization
por: Gnipp, Stefanie, et al.
Publicado: (2018)

Impact of the NO-Sensitive Guanylyl Cyclase 1 and 2 on Renal Blood Flow and Systemic Blood Pressure in Mice
por: Mergia, Evanthia, et al.
Publicado: (2018)

cGMP-dependent signaling pathways in spinal pain processing
por: Schmidtko, Achim, et al.
Publicado: (2009)

Does a reduction of vascular relaxation promote hypertension?
por: Schulte, Kathrin, et al.
Publicado: (2011)

The NO-cGMP pathway participates in vascular adaptation to oxidative stress in Nrf2 KO mice
por: Erkens, Ralf, et al.
Publicado: (2015)

Mind the gap (junction): cGMP induced by nitric oxide in cardiac myocytes originates from cardiac fibroblasts
por: Menges, Lukas, et al.
Publicado: (2019)

Modulating cGMP to Treat Lung Diseases
por: Ghofrani, Hossein-Ardeschir, et al.
Publicado: (2009)

NO signalling in synaptic transmission
por: Koesling, Doris, et al.
Publicado: (2011)

Rapid nitric oxide–induced desensitization of the cGMP response is caused by increased activity of phosphodiesterase type 5 paralleled by phosphorylation of the enzyme
por: Mullershausen, Florian, et al.
Publicado: (2001)

Contribution of the NO-GC isoforms to airway responsiveness
por: Mergia, Evanthia, et al.
Publicado: (2015)

NO/cGMP signalling in platelets
por: Schinner, Elisabeth, et al.
Publicado: (2009)

cGMP and cardiac hypertrophy
por: Perera, Ruwan K, et al.
Publicado: (2015)

Analysis of cGMP signalling with transgenic mice expressing FRET-based cGMP sensors
por: Wen, Lai, et al.
Publicado: (2013)

Transient kinetics of a cGMP-dependent cGMP-specific phosphodiesterase from Dictyostelium discoideum
Publicado: (1984)

PDE5 says NO to cGMP
por: LeBrasseur, Nicole
Publicado: (2003)

cGMP steers axons home
por: LeBrasseur, Nicole
Publicado: (2002)

A novel pathway of cGMP
por: Kuhn, Michaela, et al.
Publicado: (2011)

The role of cGMP and PKG in cardioprotection
por: Downey, James M, et al.
Publicado: (2009)

NO-cGMP signalling and cancer therapy
por: Bian, Ka, et al.
Publicado: (2013)

Role of cGMP in fat and metabolism
por: Pfeifer, Alexander, et al.
Publicado: (2013)

cGMP Signaling in Photoreceptor Degeneration
por: Li, Shujuan, et al.
Publicado: (2023)

Inhibition of the TGFβ signalling pathway by cGMP and cGMP‐dependent kinase I in renal fibrosis
por: Schinner, Elisabeth, et al.
Publicado: (2017)

cGMP: a unique 2nd messenger molecule – recent developments in cGMP research and development
por: Friebe, Andreas, et al.
Publicado: (2019)

Rational design of a PKA-based sensor for cGMP
por: Lorenz, Robin, et al.
Publicado: (2015)

Elevated retinal cGMP is not associated with elevated circulating cGMP levels in a canine model of retinitis pigmentosa
por: Occelli, Laurence M., et al.
Publicado: (2022)

The 10th International Conference on cGMP 2022: recent trends in cGMP research and development—meeting report
por: Friebe, Andreas, et al.
Publicado: (2023)

The differential roles of the two NO-GC isoforms in adjusting airway reactivity
por: Verheyen, Malte, et al.
Publicado: (2022)

Crystal structures of the carboxyl cGMP binding domain of plasmodium falciparum cGMP-dependent protein kinase reveals a novel salt bridge crucial for activation
por: Kim, Jeong Joo, et al.
Publicado: (2013)

Inhibition of p38 MAPK decreases hyperglycemia-induced nephrin endocytosis and attenuates albuminuria
por: Woznowski, Magdalena Patrycja, et al.
Publicado: (2022)

Structural and mechanistic insights into cGMP signaling
por: Rauch, Annika, et al.
Publicado: (2009)

Vascular and renal function of cGMP signalling
por: Schlossmann, Jens, et al.
Publicado: (2011)

Role of cGMP/PKG in fat tissue
por: Pfeifer, Alexander
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_quj6d2d1n31idoo6ne0ornbpf8